Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 73

1.

N-3 PUFA increase bioavailability and function of endothelial progenitor cells.

Spigoni V, Lombardi C, Cito M, Picconi A, Ridolfi V, Andreoli R, Anelli N, Gnudi L, Goldoni M, Zavaroni I, Raddino R, Dei Cas A.

Food Funct. 2014 Aug;5(8):1881-90. doi: 10.1039/c3fo60641d.

PMID:
24942553
[PubMed - in process]
2.

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study.

Pratley RE, Nauck MA, Barnett AH, Feinglos MN, Ovalle F, Harman-Boehm I, Ye J, Scott R, Johnson S, Stewart M, Rosenstock J; HARMONY 7 study group.

Lancet Diabetes Endocrinol. 2014 Apr;2(4):289-97. doi: 10.1016/S2213-8587(13)70214-6. Epub 2014 Feb 6. Erratum in: Lancet Diabetes Endocrinol. 2014 Mar;2(3):e5.

PMID:
24703047
[PubMed - in process]
3.

An ongoing role of ╬▒-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress.

Smillie SJ, King R, Kodji X, Outzen E, Pozsgai G, Fernandes E, Marshall N, de Winter P, Heads RJ, Dessapt-Baradez C, Gnudi L, Sams A, Shah AM, Siow RC, Brain SD.

Hypertension. 2014 May;63(5):1056-62. doi: 10.1161/HYPERTENSIONAHA.113.02517. Epub 2014 Feb 10.

PMID:
24516108
[PubMed - indexed for MEDLINE]
4.

Glucose-lowering drugs in patients with chronic kidney disease: a narrative review on pharmacokinetic properties.

Arnouts P, Bolignano D, Nistor I, Bilo H, Gnudi L, Heaf J, van Biesen W.

Nephrol Dial Transplant. 2014 Jul;29(7):1284-300. doi: 10.1093/ndt/gft462. Epub 2013 Dec 8.

PMID:
24322578
[PubMed - in process]
5.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

PMID:
24206459
[PubMed - indexed for MEDLINE]
Free Article
6.

Targeted glomerular angiopoietin-1 therapy for early diabetic kidney disease.

Dessapt-Baradez C, Woolf AS, White KE, Pan J, Huang JL, Hayward AA, Price KL, Kolatsi-Joannou M, Locatelli M, Diennet M, Webster Z, Smillie SJ, Nair V, Kretzler M, Cohen CD, Long DA, Gnudi L.

J Am Soc Nephrol. 2014 Jan;25(1):33-42. doi: 10.1681/ASN.2012121218. Epub 2013 Sep 5.

PMID:
24009238
[PubMed - indexed for MEDLINE]
7.

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators.

N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2.

PMID:
23992602
[PubMed - indexed for MEDLINE]
Free Article
8.

Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.

Karalliedde J, Maltese G, Hill B, Viberti G, Gnudi L.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1899-905. doi: 10.2215/CJN.02700313. Epub 2013 Aug 8.

PMID:
23929932
[PubMed - indexed for MEDLINE]
9.

Albuminuria is associated with too few glomeruli and too much testosterone.

Long DA, Kolatsi-Joannou M, Price KL, Dessapt-Baradez C, Huang JL, Papakrivopoulou E, Hubank M, Korstanje R, Gnudi L, Woolf AS.

Kidney Int. 2013 Jun;83(6):1118-29. doi: 10.1038/ki.2013.45. Epub 2013 Feb 27.

PMID:
23447063
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Effect of spironolactone and amiloride on thiazolidinedione-induced fluid retention in South Indian patients with type 2 diabetes.

Viswanathan V, Mohan V, Subramani P, Parthasarathy N, Subramaniyam G, Manoharan D, Sundaramoorthy C, Gnudi L, Karalliedde J, Viberti G.

Clin J Am Soc Nephrol. 2013 Feb;8(2):225-32. doi: 10.2215/CJN.06330612. Epub 2012 Nov 26.

PMID:
23184569
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A role for TRPV1 in influencing the onset of cardiovascular disease in obesity.

Marshall NJ, Liang L, Bodkin J, Dessapt-Baradez C, Nandi M, Collot-Teixeira S, Smillie SJ, Lalgi K, Fernandes ES, Gnudi L, Brain SD.

Hypertension. 2013 Jan;61(1):246-52. doi: 10.1161/HYPERTENSIONAHA.112.201434. Epub 2012 Nov 12.

PMID:
23150506
[PubMed - indexed for MEDLINE]
Free Article
12.

Pioglitazone improves in vitro viability and function of endothelial progenitor cells from individuals with impaired glucose tolerance.

Spigoni V, Picconi A, Cito M, Ridolfi V, Bonomini S, Casali C, Zavaroni I, Gnudi L, Metra M, Dei Cas A.

PLoS One. 2012;7(11):e48283. doi: 10.1371/journal.pone.0048283. Epub 2012 Nov 5.

PMID:
23139771
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators.

N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

PMID:
23121378
[PubMed - indexed for MEDLINE]
Free Article
14.

Cellular and molecular mechanisms of diabetic glomerulopathy.

Gnudi L.

Nephrol Dial Transplant. 2012 Jul;27(7):2642-9. doi: 10.1093/ndt/gfs121. Epub 2012 May 13. Review.

PMID:
22584788
[PubMed - indexed for MEDLINE]
Free Article
15.

VEGF and angiopoietins in diabetic glomerulopathy: how far for a new treatment?

Dei Cas A, Gnudi L.

Metabolism. 2012 Dec;61(12):1666-73. doi: 10.1016/j.metabol.2012.04.004. Epub 2012 May 1. Review.

PMID:
22554833
[PubMed - indexed for MEDLINE]
16.

Podocytes and the struggle against glucose toxicity: new targets for treatment?

Gnudi L.

Metabolism. 2012 Aug;61(8):1051-4. doi: 10.1016/j.metabol.2012.01.015. Epub 2012 Mar 3. No abstract available.

PMID:
22386941
[PubMed - indexed for MEDLINE]
17.

High prevalence of cardio-metabolic risk factors in a young urban Sri-Lankan population.

Wijesuriya M, Gulliford M, Charlton J, Vasantharaja L, Viberti G, Gnudi L, Karalliedde J.

PLoS One. 2012;7(2):e31309. doi: 10.1371/journal.pone.0031309. Epub 2012 Feb 13.

PMID:
22348068
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.

Shahni R, Gnudi L, King A, Jones P, Malik AN.

Diabetologia. 2012 Mar;55(3):825-34. doi: 10.1007/s00125-011-2373-4. Epub 2011 Nov 18.

PMID:
22095236
[PubMed - indexed for MEDLINE]
19.

DIABRISK-SL prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's--study protocol for a randomized controlled trial.

Wijesuriya M, Gulliford M, Vasantharajah L, Viberti G, Gnudi L, Karalliedde J.

Trials. 2011 Sep 26;12:209. doi: 10.1186/1745-6215-12-209.

PMID:
21943067
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy young adults.

Dei Cas A, Spigoni V, Franzini L, Preti M, Ardig├▓ D, Derlindati E, Metra M, Monti LD, Dell'Era P, Gnudi L, Zavaroni I.

Nutr Metab Cardiovasc Dis. 2013 Mar;23(3):272-8. doi: 10.1016/j.numecd.2011.04.005. Epub 2011 Aug 6.

PMID:
21824757
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk